Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty

This study has been completed.
Information provided by (Responsible Party):
Sangart Identifier:
First received: January 9, 2007
Last updated: August 15, 2013
Last verified: August 2013